Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

October 31, 2024

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

October 24, 2023

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

September 18, 2022

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

October 16, 2020

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

October 04, 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Live From Denver: TCT 2017, Day Four

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

November 02, 2017

Atrial Fibrillation: Stratifying Stroke Risk and Determining Anticoagulant Therapy

Presentation TCT 2014

Atrial Fibrillation: Stratifying Stroke Risk and Determining Anticoagulant Therapy

Presenter: Hilary Nierenberg, Julie Logan, Asma Hussaini

September 14, 2014

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Presentation TCT 2013

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Presenter: Ted Feldman

October 29, 2013

The Need for Screening for Atrial Fibrillation

Presentation TCT 2013

The Need for Screening for Atrial Fibrillation

Presenter: David Albert

October 29, 2013

Silent Atrial Fibrillation: An Under-Appreciated Threat

Presentation TCT 2013

Silent Atrial Fibrillation: An Under-Appreciated Threat

Presenter: Taya Glotzer

October 29, 2013

Presentation TCT 2013

Profile of Patients with Atrial Fibrillation in 2013: From the Highly Symptomatic Athlete to the Asymptomatic 85-Year-Old

Presenter: Mintu Turakhia

October 29, 2013

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Presentation TCT 2013

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Presenter: Vivek Reddy

October 29, 2013

Introduction: Multifaceted Approaches to Atrial Fibrillation: From Drugs to Ablation to Left Atrial Appendage Closure

Presentation TCT 2013

Introduction: Multifaceted Approaches to Atrial Fibrillation: From Drugs to Ablation to Left Atrial Appendage Closure

Presenter: Vivek Reddy

October 29, 2013

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

Presentation TCT 2013

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

Presenter: C. Michael Gibson

October 29, 2013

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Presentation TCT 2012

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Presenter: Jonathan Halperin

October 25, 2012

Does Atrial Fibrillation Ablation Reduce Cardioembolic Stroke?

Presentation TCT 2012

Does Atrial Fibrillation Ablation Reduce Cardioembolic Stroke?

Presenter: Vivek Reddy

October 24, 2012

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Presentation TCT 2012

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Presenter: Michael Ezekowitz

October 24, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.